F-18 Flurpiridaz PET MPI in Cardio-Oncology: Guiding Therapy Decisions in a Patient with New LVEF Decline During Chemo-Immunotherapy

Case Summary

This case illustrates the value of F-18 flurpiridaz PET myocardial perfusion imaging in guiding cancer therapy decisions in a patient with new LVEF decline during chemo-immunotherapy.

Resource Type

Cases

Clinical Topic

Cardiac PET, Myocardial Perfusion Imaging (MPI), Radiotracers

Related Resources

Cases

PET Case: Visual Perfusion vs Absolute Blood Flow: Differences in Imaging Agents

Case Summary This case illustrates how the differences in tracer extraction fraction…

View This Resource
Cases

PET Case: The Mystery of Chest Pain with Patent Grafts

Case summary:  This case illustrates the added value of myocardial blood flow…

View This Resource
Cases

PET Case: This is Why We Do Cardiac PET: Comparison of SPECT and PET in the Same Patient

Case summary: A 60-year-old patient with recurring exertional angina undergoes cardiac PET…

View This Resource